Oncology Market Access in India – The Commercial Potential is High, but Many Challenges Remain

</tr>

Research and Markets (http://www.researchandmarkets.com/research/d1d072/oncology_market_ac) has announced the addition of the "Oncology Market Access in India - The commercial potential is high, but many challenges remain" report to their offering.

The Indian oncology market is forecast to grow strongly in the next decade, driven by the rise in cancer incidence and diagnosis, improved access to cancer therapies, better health insurance coverage, and higher pharmaceutical spending, particularly among the growing middle class. But while pharmaceutical companies are keen to establish a strong presence in India, a number of challenges remain

Features and benefits

Analysis of the current epidemiology and trends within the Indian oncology market

In-depth analysis of the opportunities and threats for oncology companies in India

Discussion of key multinational and domestic companies in the Indian cancer market

An analysis of the key factors for success in India in the context of the overall healthcare industry

Highlights

A large part of the Indian population lacks access to appropriate cancer care. A number of reasons contribute to this including inadequate healthcare infrastructure, low health insurance coverage, poor education and low cancer awareness.

While domestic companies dominate the market with branded generics, all major multinational pharmaceutical companies have a presence in India, targeting a small but significant part of the population that can afford the price premium associated with global brands.

As the Indian economy continues to grow, more people will gain the financial ability to seek cancer treatment, while the growing middle class will drive demand for innovative branded therapies. Plans to increase government expenditure on health and improve access to cancer drugs will also drive the uptake of cancer therapeutics in the future

Your key questions answered

Appreciate the structure of cancer care delivery in India, as well as the factors that influence the nature and quality of cancer treatment

Evaluate the opportunities and threats facing multinational companies wishing to establish or expand their presence in the Indian oncology market

Identify strategies for market penetration and appreciate the key factors for commercial success

For more information visit http://www.researchandmarkets.com/research/d1d072/oncology_market_ac Source: Datamonitor